Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Clofarabine in Relapsed/Refractory Non-Hodgkin Lymphoma
NCT00644189Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2008
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clofarabine in non-Hodgkin lymphoma (NHL), sponsored by Massachusetts General Hospital. Primary endpoint: Overall Response Rate at 6 months. Started Jun 2008; status: completed.
02
Drugs
clofarabine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00644189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644189.